Am J Surg
- MOUSSALLY M, GamalEldin MM, Lapinski JE, Willner K, et al
Close margin of adverse histologic factors with a negative primary tumor margin
is not associated with increased locoregional recurrence in colon cancer.
Am J Surg. 2024 Jun 19:115804. doi: 10.1016/j.amjsurg.2024.115804.
Ann Oncol
- CECCHINI M, Sundar R
Proofreading the way: immune checkpoint inhibitors in polymerase epsilon/polymerase delta
(POLE/POLD1)-altered colorectal cancer.
Ann Oncol. 2024;35:582-584.
Ann Surg Oncol
- STEFFENS D, Nott F, Koh C, Jiang W, et al
Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following
Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15593.
- SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
The Association of Mismatch Repair Status with Microscopically Positive (R1)
Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study.
Ann Surg Oncol. 2024 Jun 21. doi: 10.1245/s10434-024-15595.
Anticancer Res
- KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent
Local Recurrences of Rectal Cancer.
Anticancer Res. 2024;44:3205-3211.
- LEE SH, Kim SA, Park SJ, Lee MY, et al
NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity
Against SW480 Colorectal Cancer Cells.
Anticancer Res. 2024;44:2909-2919.
- SHIOI I, Ogawa H, Naito R, Endo M, et al
Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for
Colorectal Cancer.
Anticancer Res. 2024;44:3013-3023.
- TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in
Patients With Colorectal Cancer.
Anticancer Res. 2024;44:2933-2941.
- KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer
Biomarkers in Colorectal Cancer.
Anticancer Res. 2024;44:3105-3113.
BMC Cancer
- XU M, Chen Y, Li P, Ye Q, et al
Antibiotic use during radical surgery in stage I-III colorectal cancer:
correlation with outcomes?
BMC Cancer. 2024;24:769.
- XU J, Pan L, Wu D, Yao L, et al
Comparison of the diagnostic value of various microRNAs in blood for colorectal
cancer: a systematic review and network meta-analysis.
BMC Cancer. 2024;24:770.
- LI A, Li Q, Wang C, Bao X, et al
Constructing a prognostic model for colon cancer: insights from immunity-related
genes.
BMC Cancer. 2024;24:758.
Br J Cancer
- YANG L, Yi J, He W, Kong P, et al
Correction: Death receptors 4/5 mediate tumour sensitivity to natural killer
cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.
Br J Cancer. 2024 Jun 26. doi: 10.1038/s41416-024-02768.
Clin Cancer Res
- JOHANSEN AM, Forsythe SD, McGrath CT, Barker G, et al
TGFbeta in pancreas and colorectal cancer: opportunities to overcome therapeutic
resistance.
Clin Cancer Res. 2024 Jun 25. doi: 10.1158/1078-0432.CCR-24-0468.
Gastroenterology
- FORBES N
Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection for Large
Colonic Adenomas.
Gastroenterology. 2024;167:409.
- DJINBACHIAN R, Haumesser C, Taghiakbari M, Pohl H, et al
Autonomous Artificial Intelligence vs Artificial Intelligence-Assisted Human
Optical Diagnosis of Colorectal Polyps: A Randomized Controlled Trial.
Gastroenterology. 2024;167:392-399.
- WEI J, Zhao S, Bai Y
Impact of Texture and Color Enhancement Imaging on Adenoma and Sessile Serrated
Lesion Detection: Much More to Explore.
Gastroenterology. 2024;167:413-414.
Gastrointest Endosc
- PETERSEN MM, Kleif J, Liggett J, Rasmussen M, et al
Development of an algorithm combining blood-based biomarkers, fecal
immunochemical test, and age for population-based colorectal cancer screening.
Gastrointest Endosc. 2024 Jun 20:S0016-5107(24)03290.
Hum Pathol
- JAN YH, Lu CT, Lam AK
Comparison of genomic profiling of patient-matched primary colorectal and
surgical resected distant metastatic (stage IV) colorectal carcinoma for drug
actionability.
Hum Pathol. 2024;149:21-28.
Int J Colorectal Dis
- CHEN H, Zhang JH, Hao Q, Wu XL, et al
Analysis of tumor microenvironment alterations in partially responsive rectal
cancer patients treated with neoadjuvant chemoradiotherapy.
Int J Colorectal Dis. 2024;39:99.
- ZHENG Z, Luo H, Deng K, Li Q, et al
Evaluating the prognostic value of tumor deposits in non-metastatic lymph
node-positive colon adenocarcinoma using Cox regression and machine learning.
Int J Colorectal Dis. 2024;39:97.
- DE MORAES FCA, Kelly FA, Souza MEC, Burbano RMR, et al
Impact of adjuvant chemotherapy on survival after pathological complete response
in rectal cancer: a meta-analysis of 31,558 patients.
Int J Colorectal Dis. 2024;39:96.
J Surg Oncol
- SURAJU MO, Freischlag K, McKeen A, Nayyar A, et al
Evaluation of association between center colorectal neuroendocrine neoplasm
volume and survival among patients with colorectal neuroendocrine carcinoma.
J Surg Oncol. 2024;129:1449-1455.
- CAI M, Cotter RR, Wong SL, Mayo SW, et al
Evaluating clinical practice guidelines for the management of rectal cancer: Did
they get it RIGHT?
J Surg Oncol. 2024;129:1475-1480.
Lancet
- ENG C, Yoshino T, Ruiz-Garcia E, Mostafa N, et al
Colorectal cancer.
Lancet. 2024 Jun 20:S0140-6736(24)00360-X. doi: 10.1016/S0140-6736(24)00360.
Lancet Oncol
- LIN HW, Cheng CY
Painful annular skin rash on both legs in a patient with rectal cancer.
Lancet Oncol. 2024;25:e331.
PLoS One
- JIRAPONGWATTANA N, Thongchot S, Pongpaibul A, Trakarnsanga A, et al
The combined tumour-based Fascin/Snail and stromal periostin reveals the
effective prognosis prediction in colorectal cancer patients.
PLoS One. 2024;19:e0304666.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016